Sante Ventures — Full Portfolio
18 tracked investments · listed companies and verified rows first
Aimbient builds an ambient AI platform for procedural medicine that automatically captures clinical cases and generates actionable intelligence for healthcare teams to improve patient care and operational outcomes.
AI & Machine LearningHealthtechMedical DevicesNew York, US
Co-investorsUS Venture Partners
Non-surgical, non-pharmacologic devices to induce weight loss
Co-investorsDelos CapitalLongitude CapitalArboretum VenturesHighland Capital Partners
BeeKeeperAI enables healthcare AI developers and researchers to access diverse, real-world clinical data while keeping it secure within private cloud infrastructure.
AI & Machine LearningCybersecurityData & InfrastructureDigital HealthHealthtech
Co-investorsAIX Ventures
Clairity develops direct air capture and mineralization technology to remove carbon dioxide from the atmosphere.
CleantechClimate TechDeep TechHealthtechSouthern Nevada, US
BoardJoe Cunningham(Director)Kevin Lalande(Executive Officer, Director)
Co-investorsLOWERCARBONLowercarbon Capital
EndoStim develops a neurostimulation medical device system for treating drug-resistant gastroesophageal reflux disease (GERD) by restoring esophageal function while preserving normal anatomy.
BiotechHealthtechMedical DevicesSt. Louis, US
Eric Goorno(Chief Executive Officer)Greg Wilson(Chief Financial Officer)Stephen Attwood, MD(Surgical Director)Virender Sharma, MD(Chief Medical Officer)Hazim Ansari(Chief Legal Counsel)Bevil J. Hogg(Executive Officer, Director)
Co-investorsRelevance Ventures
KelaHealth develops data-driven solutions that apply insights from millions of patient records to personalize and improve medical decision-making.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechMedical DevicesSan Francisco, US
Bora Chang(Executive Officer, Director)
BoardDennis McWilliams(Director)
Co-investorsBlue Hour VenturesIDEA NCIntuitive VenturesNueterra CapitalTechstars
Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.
BiotechHealthtechAustin, US
Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in
Co-investorsNew Enterprise Associates (NEA)Clarus VenturesDeerfield Management CompanySante Health VenturesWellcome Trust
OutcomesAI combines AI voice agents with licensed nurses to deliver scalable, high-quality care across hospitals, virtual care, and specialty programs.
AI & Machine LearningDigital HealthHealthtech
Kuldeep Singh Rajput(Founder)
Co-investorsHeadwater Ventures
Reimagine Care partners with cancer providers and health systems to deliver virtual oncology care combining AI-powered support, clinical expertise, and digital monitoring to manage symptoms, reduce emergency visits, and improve patient outcomes outside the clinic setting.
AI & Machine LearningDigital HealthHealthtechNashville, US
Dan Nardi(Mr. Nardi is the CEO and a director of the Issuer)Keith Figlioli(Director)Feby Abraham(Director)Chris Stenzel(Director)
BoardDouglas French(Director)Harlan Levine(Director)in
Co-investorsCU Healthcare Innovation FundMartin VenturesMcKesson VenturesOncology VenturesLRVHealth
Reprieve Cardiovascular develops a decongestion management system that uses real-time patient data to guide and personalize diuretic therapy for fluid removal in heart failure patients.
Digital HealthHealthtechMedical DevicesMilford, US
Tony Fields(Executive Officer)Adam Bartnik(Executive Officer)inMark Pacyna(Executive Officer, Director)inJim Dillon(Executive Officer, Director)Hanson S. Gifford III(Director)Gregory W Mann(Executive Officer)
Co-investorsArboretum VenturesLightstone VenturesRex Health VenturesDeerfield Management CompanyGenesis Venture Capital
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Co-investorsBonaventure Equity, LLCHatteras Venture PartnersIter InvestmentsMission BiocapitalRoute 66 VenturesService Provider Capital+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
beHuman HealthBradoNirogy TherapeuticsRapidPulseRiseHealthSONIRE TherapeuticsTerapio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.